Bausch + Lomb owner Valeant Pharmaceuticals has added a new manufacturing line in the US for its Ultra range of contact lenses.
A ribbon cutting ceremony was held this week for the expansion, which adds 120 new jobs to the Rochester, New York facility.
A solar array was also currently under construction at the plant, to generate greener electricity through the installation of 3,667 solar panels.
Michael Pearson, Valeant chairman and chief executive officer, said: ‘Our Rochester facility is a very important piece of our strategy to rebuild Bausch + Lomb as one of the leading contact lens producers.
‘Our Rochester optics centre is a first in class manufacturing site for contact lens manufacturing and distribution, and with the new contact lens manufacturing lines, we will add much needed production capacity to supply both current and future demand. I want to thank both Senator Schumer and the state of New York for their support of this project.’
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here